Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current issues in neonatal transfusions.

R G Strauss

    Vox Sanguinis
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Neonatal erythrocyte transfusions are recommended for infants with anemia-induced heart failure and specific symptoms. Granulocyte transfusions may benefit critically ill neonates with sepsis, neutropenia, and low neutrophil stores.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A multicentre study investigating vital sign changes occurring in complicated and uncomplicated transfusions.

    Vox sanguinis·2017
    Same author

    Clinical and laboratory correlates of platelet alloimmunization and refractoriness in the PLADO trial.

    Vox sanguinis·2016
    Same author

    Education in transfusion medicine for medical students and doctors.

    Vox sanguinis·2013
    Same author

    Preparation of granulocyte concentrates by apheresis: collection modalities in the USA.

    Vox sanguinis·2011
    Same author

    Neonatal transfusions.

    Vox sanguinis·2009
    Same author

    The future use of pathogen-inactivated platelet concentrates.

    Vox sanguinis·2003
    Same journal

    Barriers and enablers to non-remunerated plasma donation: A meta-synthesis of the qualitative literature using the theoretical domains framework.

    Vox sanguinis·2026
    Same journal

    Haemolytic disease of the foetus and newborn due to anti-M: A systematic review.

    Vox sanguinis·2026
    Same journal

    In vitro evaluation of apheresis platelet and plasma products collected and stored in non-DEHP disposable sets.

    Vox sanguinis·2026
    Same journal

    Survey of national and regional rare donor programmes regarding Immunoglobulin A deficiency.

    Vox sanguinis·2026
    Same journal

    Fibrinogen recovery in cryoprecipitate prepared from thawed plasma stored for 5 days post-thaw.

    Vox sanguinis·2026
    Same journal

    Abstracts of the 39th International Congress of the ISBT, Kuala Lumpur, Malaysia, 20-24 June 2026.

    Vox sanguinis·2026
    See all related articles

    Area of Science:

    • Neonatal Medicine
    • Hematology
    • Pediatric Critical Care

    Background:

    • Neonatal transfusion practices, including erythrocyte 'booster' transfusions and granulocyte transfusions, are subjects of ongoing debate.
    • Current guidelines for these transfusions in neonates require critical review and updated recommendations.

    Purpose of the Study:

    • To critically review controversial neonatal transfusion practices.
    • To provide current recommendations for erythrocyte and granulocyte transfusions in neonates.

    Main Methods:

    • Literature review and critical analysis of existing studies on neonatal transfusion practices.
    • Formulation of evidence-based recommendations for clinical application.

    Main Results:

    Related Experiment Videos

  • Erythrocyte transfusions are indicated for neonatal congestive heart failure due to anemia.
  • Erythrocyte transfusions may be beneficial for infants with anemia and symptoms like apnea or poor weight gain.
  • Granulocyte transfusions are recommended for neonates with bacterial sepsis, neutropenia, and depleted neutrophil stores.
  • Conclusions:

    • Erythrocyte transfusions should be administered to neonates with anemia-related congestive heart failure and specific clinical indicators.
    • Granulocyte transfusions offer potential benefits for severely ill neonates with confirmed sepsis and specific hematological criteria.
    • The use of granulocyte transfusions in neonates with fewer than three of the specified criteria should be considered experimental.